AERI - Aerie Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow

Income statement

Annual
All numbers in thousands
Revenue31/12/201831/12/201731/12/201631/12/2015
Total revenue24,181---
Cost of revenue27,18616,7109,772-
Gross profit-3,005-16,710-9,772-
Operating expenses
Research development86,12372,07852,39444,451
Selling general and administrative120,61456,90534,70630,635
Non-recurring----
Others----
Total operating expenses233,923145,69396,87275,086
Operating income or loss-209,742-145,693-96,872-75,086
Income from continuing operations
Total other income/expenses net-22,824-1,170-1,994862
Earnings before interest and taxes-209,742-145,693-96,872-75,086
Interest expense-2,531-2,368-2,537-2,493
Income before tax-232,566-146,863-98,866-74,224
Income tax expense3-1,758193139
Minority interest----
Net income from continuing ops-232,569-145,105-99,059-74,363
Non-recurring events
Discontinued operations----
Extraordinary items----
Effect of accounting changes----
Other items----
Net income
Net income-232,569-145,105-99,059-74,363
Preferred stock and other adjustments----
Net income applicable to common shares-232,569-145,105-99,059-74,363
By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes